Cardiol Therapeutics Class Stock Alpha and Beta Analysis
| CRDL Stock | USD 1.62 0.04 2.53% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Cardiol Therapeutics Class. It also helps investors analyze the systematic and unsystematic risks associated with investing in Cardiol Therapeutics over a specified time horizon. Remember, high Cardiol Therapeutics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Cardiol Therapeutics' market risk premium analysis include:
Beta 0.67 | Alpha (0.28) | Risk 3.78 | Sharpe Ratio (0.05) | Expected Return (0.18) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Cardiol |
Cardiol Therapeutics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Cardiol Therapeutics market risk premium is the additional return an investor will receive from holding Cardiol Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cardiol Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Cardiol Therapeutics' performance over market.| α | -0.28 | β | 0.67 |
Cardiol Therapeutics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Cardiol Therapeutics' Buy-and-hold return. Our buy-and-hold chart shows how Cardiol Therapeutics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Cardiol Therapeutics Market Price Analysis
Market price analysis indicators help investors to evaluate how Cardiol Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardiol Therapeutics shares will generate the highest return on investment. By understating and applying Cardiol Therapeutics stock market price indicators, traders can identify Cardiol Therapeutics position entry and exit signals to maximize returns.
Cardiol Therapeutics Return and Market Media
The median price of Cardiol Therapeutics for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 is 1.91 with a coefficient of variation of 10.41. The daily time series for the period is distributed with a sample standard deviation of 0.2, arithmetic mean of 1.93, and mean deviation of 0.14. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Cardiol Therapeutics Inc Shares Up 8.74 percent on Sep 9 | 09/09/2024 |
2 | Cardiol Therapeutics Achieves Target Patient Enrollment in its Phase II ARCHER Trial Investigating CardiolRx for Acute Myocarditis - Investing News Network | 09/25/2024 |
3 | AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday | 10/09/2024 |
4 | Are Medical Stocks Lagging Cardiol Therapeutics This Year | 10/22/2024 |
5 | Cardiol Therapeutics Reports Promising Phase II Results - TipRanks | 11/18/2024 |
6 | What is HC Wainwrights Forecast for CRDL FY2024 Earnings - MarketBeat | 11/22/2024 |
About Cardiol Therapeutics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Cardiol or other stocks. Alpha measures the amount that position in Cardiol Therapeutics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 (projected) | Days Sales Outstanding | 1.7K | 1.5K | PTB Ratio | 2.51 | 2.38 |
Cardiol Therapeutics Upcoming Company Events
As portrayed in its financial statements, the presentation of Cardiol Therapeutics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Cardiol Therapeutics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Cardiol Therapeutics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Cardiol Therapeutics. Please utilize our Beneish M Score to check the likelihood of Cardiol Therapeutics' management manipulating its earnings.
| 26th of March 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Cardiol Therapeutics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Cardiol Therapeutics Backtesting, Cardiol Therapeutics Valuation, Cardiol Therapeutics Correlation, Cardiol Therapeutics Hype Analysis, Cardiol Therapeutics Volatility, Cardiol Therapeutics History and analyze Cardiol Therapeutics Performance. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Cardiol Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.